CytoReason

View the org chart displaying its 12 main executives

Most searched biographies at CytoReason

• David Harel, Chief Executive Officer
• Ofek Levy, Vice President of Finance
• Michal Katzir, Vice President, Human Resources

Create your alert
to follow the executive moves at CytoReason.

CytoReason has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
• Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by CytoReason

Social media about CytoReason

• CytoReason on Wikipedia, Google News & Yahoo Finance
• CytoReason on LinkedIn, Twitter & YouTube

Contact by email its executives including David Harel

Call CytoReason at +972 ...

View the org chart

Register to receive your alert

Report an error